Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2011 Jun;13(3):573-576.
doi: 10.1007/s11307-010-0367-0.

Clinical utility of positron emission tomography/computed tomography in inflammatory bowel disease

Affiliations
Clinical Trial

Clinical utility of positron emission tomography/computed tomography in inflammatory bowel disease

Robert T Lapp et al. Mol Imaging Biol. 2011 Jun.

Abstract

Purpose: The clinical utility of positron emission tomography/computed tomography (PET/CT) in comparison to standard workup in patients with known or suspected inflammatory bowel disease (IBD) is unknown.

Procedures: Clinical data were collected on seven patients with known or suspected IBD undergoing PET/CT. Standard workup included history, physical exam, laboratory tests, colonoscopy and/or cross-sectional imaging. We divided the intestine into five regions [small bowel and four colon (ascending, transverse, descending and rectosigmoid)] and graded relative standard uptake values 0, 1, 2 or 3 by comparison to the liver, using a region-of-interest analysis (0 = no activity, 1 = liver, 2 and 3 = significant inflammation).

Results: In patients 1 and 2, PET/CT demonstrated more activity than we thought clinically present. The other patients avoided unnecessary escalation or initiation of IBD therapy based on PET/CT results. Compared with standard workup, all seven patients had superior results when therapeutic decisions were based on PET/CT.

Conclusions: We found PET/CT to be very useful in diagnosis and management in patients with known or suspected IBD.

PubMed Disclaimer

References

    1. Inflamm Bowel Dis. 2010 Jan;16(1):112-24 - PubMed
    1. Lancet. 1997 Jul 26;350(9073):262 - PubMed
    1. Q J Nucl Med Mol Imaging. 2009 Feb;53(1):64-71 - PubMed
    1. N Engl J Med. 2009 Nov 19;361(21):2066-78 - PubMed
    1. Inflamm Bowel Dis. 2005 Aug;11(8):733-8 - PubMed

Publication types